Biosig announces proposed public offering of common stock

Westport, ct, july 01, 2021 (globe newswire) --   biosig technologies, inc. (nasdaq: bsgm) (“biosig” or the “company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ecg and intra-cardiac signals, today announced that it has commenced an underwritten public offering of its common stock. biosig also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of common stock offered in the public offering. the offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
BSGM Ratings Summary
BSGM Quant Ranking